Other key factors in the interaction between gut microbiota and NAFLD are BAs and the molecules (e.g., farnesoid X receptor [FXR]) that regulate BA synthesis. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.